申请人:——
公开号:US20040014809A1
公开(公告)日:2004-01-22
A compound of the formula
1
wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, X
1
and X
2
are as defined in the specification useful for the treatment of diseases in which action of the neurokinin 1 receptor is implicated, methods of using such compounds and pharmaceutical compositions comprising such compounds.
一种化合物的公式如下,其中R1、R2、R3、R4、R5、R6、X1和X2如规范中定义,用于治疗神经激肽1受体作用所涉及的疾病,使用这种化合物的方法以及包含这种化合物的药物组合物。